Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-25 @ 2:28 AM
NCT ID:
NCT03265834
Eligibility Criteria:
Inclusion Criteria:
* Adults \>18 years
* The diagnosis of a definite CABI
* Capable of giving informed consent
* No practical or clinical barriers to consuming 28 days of antibiotic therapy, which may include consumption of antibiotics at home
Exclusion Criteria:
* a CABI diagnosed within the previous year
* a CABI diagnosed \>6 days prior to screening
* uncomplicated cholecystitis/cholangitis/gall bladder empyema (no perforation or extra-biliary abscess
* a skin and soft tissue infection/abscess not communicating with the peritoneal space
* primary complicated or uncomplicated appendicitis managed surgically
* intra-abdominal infection associated with pancreatitis, pelvic inflammatory disease, primary (spontaneous) bacterial peritonitis (SBP), continuous ambulatory peritoneal dialysis peritonitis (CAPD peritonitis) and Clostridium difficile infection. concurrent infection requiring more than 10 days of therapy
* Infection with a highly resistant bacterium such that antibiotic treatment is considered to be a significantly sub-optimal by the treating microbiologist e.g. multi-resistant carbapenemase producing Entrobacteriacea
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03265834
Study Brief:
Protocol Section:
NCT03265834